Research
Print page
Switch language
Rigshospitalet
- a part of Copenhagen University Hospital
Published
Genetic polymorphisms of tumour necrosis factor receptor superfamily 1b and fas ligand are associated with clinical efficacy and/or acute severe infusion reactions to infliximab in Crohn's disease
Research output: Contribution to journal › Journal article › Research › peer-review
Single nucleotide polymorphisms (SNPs) in TNF receptor superfamily (TNFRSF) 1A and 1B, and Fas ligand (FASLG) genes, have been associated with responsiveness to infliximab (IFX) in Crohn's disease.
| Original language | English |
|---|---|
| Journal | Alimentary Pharmacology and Therapeutics |
| Volume | 36 |
| Issue number | 7 |
| Pages (from-to) | 650-9 |
| Number of pages | 10 |
| ISSN | 0269-2813 |
| DOIs | |
| Publication status | Published - 2012 |
ID: 36603496